Can music retrain the brain after psychosis? new study tests Computer-Assisted therapy
NCT ID NCT05880719
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study explores whether computer-assisted music remediation can improve memory, attention, and thinking in young people aged 18 to 30 who have had a first psychotic episode. Participants attend weekly group sessions using music software to practice memory and executive skills. The study measures changes in cognitive function and mood over 10 weeks.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- computer-assisted music remediation
- What this could lead to
- If it works, this could point toward a non-drug therapy to help young people recover memory and thinking skills after a first psychotic episode.
- What could go wrong
- This is a small pilot study with only 30 participants, so results may not apply broadly. It is early-stage research, and the therapy may not produce lasting cognitive improvements.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2023
- Expected to finish
-
Jun 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 30 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient aged 18 to 30 years. * Consult for a first psychotic episode according to the criteria of the DSM-V * Francophone patient * With at least one memory deficit highlighted at the neuropsychological assessment of entry into the EMSI * Benefiting from a follow-up within the EMSI * Affiliated to the social security system * Clinically stabilized patient one month away from psychiatric hospitalization * Patient who has been informed of the study and has given his informed consent. Exclusion Criteria: Inability to give the patient informed information * Not meeting the criteria of the DSM-V of first episode of psychosis * Absence of memory cognitive disorders at the neuropsychological assessment of entry into the EMSI department. * Patient who has already had cognitive remediation in his EMSI management. * Patients under judicial protection measure (guardianship or curatorship).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Psychotic episode are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CAEN University Hospital
RECRUITINGCaen, 14033, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.